Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.31 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | EDNRB | P24530 | 1/20 | 0.31 |
| ▸ | EDNRA | P25101 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | TYMP | P19971 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25781415 | 0.95 | CA12 (0.33) | — | |
| SCHEMBL4194210 | 0.94 | EDNRB (0.32) | GABRA1GABRG2GABRB3EDNRBEDNRA | |
| SCHEMBL13447366 | 0.92 | CA12 (0.34) | EDNRBEDNRA | |
| SCHEMBL12640650 | 0.90 | CA12 (0.32) | KDM4EALDH1A1ATMHSD17B10 | |
| SCHEMBL24177858 | 0.90 | SIRT2 (0.30) | — | |
| SCHEMBL13447248 | 0.87 | CA12 (0.34) | EDNRBEDNRA | |
| SCHEMBL24973903 | 0.86 | PDE9A (0.33) | GABRA1GABRG2GABRB3ALOX5CYP1A2 | |
| SCHEMBL13447247 | 0.86 | CA12 (0.35) | EDNRBEDNRA | |
| SCHEMBL24599931 | 0.85 | KDM4E (0.31) | KDM4E | |
| SCHEMBL179257 | 0.85 | HSD17B1 (0.35) | GABRA1GABRG2GABRB3ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11800785-B2 | Material for organic device and organic electroluminescent device using the same | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2023-10-24 | — | — | US | disclosed |
| US-20220006012-A1 | MATERIAL FOR ORGANIC DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2022-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11800785-B2 | Material for organic device and organic electroluminescent device using the same | RER1, LEF1, CHRM1 | GABRA1 3748/4885GABRG2 4451/4885GABRB3 4683/4885 |
| US-20220006012-A1 | MATERIAL FOR ORGANIC DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | RER1, LEF1, CHRM1 | GABRA1 3748/4885GABRG2 4451/4885GABRB3 4683/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.